Fig. 7From: Region-specific glucocorticoid receptor promoter methylation has both positive and negative prognostic value in patients with estrogen receptor-positive breast cancerKaplan-Meier curves of overall survival (a, c) and disease-free survival (b, d) according to methylation of GR bisulfite sequencing region U (a, b) and methylation of GR bisulfite sequencing region C (c, d) in the MA.12 cohort. P values were derived from log-rank testsBack to article page